HIV / AIDS in the News

ViiV's Dovato matches Gilead's Biktarvy in first head-to-head HIV trial - The Pharma Letter

 

HIV funding fell by $2bn last year fuelled by Trump’s aid cuts, new reports find - AOL.com

 

Advocates puzzled after HIV is left off of Georgia’s ‘medically frail’ list for Medicaid work rules - WABE

 

HIV funding fell by $2bn last year fuelled by Trump’s aid cuts, new reports find - The Independent

 

amfAR Commits Nearly $2 Million Toward Four New HIV Cure-Focused Studies - amfAR, The Foundation for AIDS Research

 

Global HIV funding falls to 20-year low - Semafor

 

Innovation Without Access is Injustice: AIDS 2026 Opens in Rio - avac.org

 

KI Researcher Unveils Fashion Highlighting HIV Challenges - Mirage News

 

HIV progress in 'real danger' as global funding plummets - ABS-CBN

 

Scientifically, lenacapavir PrEP takes a victory lap. But now worries about access | AIDS 2026 - Managed Healthcare Executive

 

Global HIV funding falls to 20-year low - Yahoo

 

Integration, Innovation and Community Leadership Key to Ending HIV, Hepatitis and STIs - POZ

 

Anthony Fauci’s pandemic-era diary entries - STAT

 

HIV resurgence looming as international aid declines - pharmaphorum

 

Cendaña to Marcos: Youth can’t get HIV from porn, cancel culture - Inquirer.net

 

UNAIDS Warns HIV Could Resurge As Global Funding Falls - Yahoo Life UK

 

Four-paper series broadens sex workers' health focus beyond HIV prevention - Medical Xpress

 

HIV Funding Cuts Threaten Global Fight Against AIDS - teleSUR English

 

ViiV’s two-drug Dovato matches three-drug Biktarvy in first head-to-head HIV trial - AllSci

 

Pennsylvania ends HIV sentencing enhancements to reduce stigma - PinkNews

 

Amid U.S. funding cuts, the International AIDS Conference faces an uncertain future - NPR

 

ViiV’s two-drug Dovato matches three-drug Biktarvy in first head-to-head HIV trial - AllSci

 

Advocates puzzled after HIV is left off of Georgia’s ‘medically frail’ list for Medicaid work rules - Georgia Recorder

 

Global HIV response at risk as funding cuts raise fears of epidemic resurgence - United Nations in India

 

New report reveals consequences of Trump administration's HIV/AIDS funding cuts - PBS

 

The Next Step on the Path to an HIV Cure - amfAR | The Foundation for AIDS Research

 

Funding for the Global HIV Response Plunged in 2025, With Devastating Consequences - POZ

 

Gilead uses humor in ‘Up to Date’ HIV prevention push - Fierce Pharma

 

Global HIV Response Falters as Reemergence Looms - POZ

 

HIV Dovato Noninferior to Biktarvy at 48 Weeks - Infectious Disease Special Edition